Trials / Completed
CompletedNCT02235155
Mifepristone and Misoprostol for Midtrimester Termination of Pregnancy in Uzbekistan
Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy (13-22 Weeks LMP) in Uzbekistan
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 135 (actual)
- Sponsor
- Gynuity Health Projects · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Accepted
Summary
The primary goal is to examine the efficacy and feasibility of a mifepristone-misoprostol medical abortion regimen in terminating pregnancies 13-22 weeks in Uzbekistan.
Conditions
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2015-11-01
- Completion
- 2015-11-01
- First posted
- 2014-09-09
- Last updated
- 2016-01-14
Locations
3 sites across 1 country: Uzbekistan
Source: ClinicalTrials.gov record NCT02235155. Inclusion in this directory is not an endorsement.